These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 32931661)
1. Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database. Li X; Guo K; Feng Y; Guo Y Cancer Med; 2020 Nov; 9(21):8029-8042. PubMed ID: 32931661 [TBL] [Abstract][Full Text] [Related]
2. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study. Zhu X; Zhou J; Zhou L; Zhang M; Gao C; Tao L J Transl Med; 2022 Sep; 20(1):405. PubMed ID: 36064552 [TBL] [Abstract][Full Text] [Related]
3. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma. Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913 [TBL] [Abstract][Full Text] [Related]
4. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107 [TBL] [Abstract][Full Text] [Related]
5. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study. Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465 [TBL] [Abstract][Full Text] [Related]
7. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis. Shen W; Sakamoto N; Yang L Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937 [TBL] [Abstract][Full Text] [Related]
8. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy. Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for primary cancer can reduce the risk of head and neck second primary malignancy: a propensity-matched analysis. Xiong L; Yu H; Wei W; Wang C; Li B; Liu H; Cheng A; Li D; Han Z; Feng Z Clin Oral Investig; 2023 Feb; 27(2):571-580. PubMed ID: 36239788 [TBL] [Abstract][Full Text] [Related]
10. Second primary lung malignancy following head and neck squamous cell carcinoma. Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703 [TBL] [Abstract][Full Text] [Related]
11. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010). Jung YS; Lim J; Jung KW; Ryu J; Won YJ PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068 [TBL] [Abstract][Full Text] [Related]
12. Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools. Wang SW; Chan LP; Wang LF; Wu CW; Lin SH; Huang TY; Lee KW PLoS One; 2022; 17(2):e0263773. PubMed ID: 35167611 [TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid Carcinoma in the Head and Neck: A Population-Based Analysis of Outcome and Survival. Ding L; Bi ZF; Yuan H; Zhao XH; Guan XD; Yao HR; Liu YM Laryngoscope; 2021 Feb; 131(2):E489-E499. PubMed ID: 33135805 [TBL] [Abstract][Full Text] [Related]
14. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis. Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study. Xiao Y; Peng S; Hu Y; Zhang J; Cao X Cancer Med; 2020 Nov; 9(22):8562-8570. PubMed ID: 32941704 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study. Liu Y; Zhang P; Zhang Y; Zheng L; Xu W; Hou D; Kang Z Sci Rep; 2021 Jan; 11(1):1293. PubMed ID: 33446816 [TBL] [Abstract][Full Text] [Related]
17. Real-world impact of chemotherapy on overall survival in craniomaxillofacial osteosarcoma. Li YH; Zheng L; Chen GC; Zhang YM; Xu YZ; Huang YF J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101807. PubMed ID: 38431082 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma. Cui J; Wang L; Zhong W; Chen Z; Tan X; Yang H; Chen J; Liu G Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744320 [TBL] [Abstract][Full Text] [Related]
19. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Shen W; Sakamoto N; Yang L Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664 [TBL] [Abstract][Full Text] [Related]
20. A model and nomogram to predict tumor site origin for squamous cell cancer confined to cervical lymph nodes. Ali AN; Switchenko JM; Kim S; Kowalski J; El-Deiry MW; Beitler JJ Cancer; 2014 Nov; 120(22):3469-76. PubMed ID: 25060659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]